The FDA last year approved semaglutide, which was developed initially as a treatment for type 2 diabetes, for weight loss in adults. But researchers wanted to know if the drug could also help adolescents lose weight.
22.2% of 12- to 19-year-olds from 2017 to 2020, according to the CDC.
Adolescent obesity is a very difficult subject to navigate, Bazzano adds. “You have to engage the entire family, and not just the child. It has to be at the level of the whole family, and that can be very challenging. If the entire family engages together, there can be a modest weight loss.” “We need to see long-term outcomes from chronic medication use and whether weight rebounds when adolescents stop using the medication,” she says.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA links opioid overdoses to animal sedative not for human consumptionThe FDA says overdoses caused by the animal medication xylazine is hard to distinguish from opioids for humans.
Read more »
FDA warns of risks from xylazine, an animal drug linked to overdoses in humansThe Food and Drug Administration warned that overdoses from xylazine mirror opioid overdoses, but may not be reversed by naloxone.
Read more »
Why There Isn’t an RSV Vaccine to Combat the Current SurgePfizer will submit results of a phase 3 trial to the FDA soon.
Read more »
U.S.FDA panel votes against Veru's COVID-19 pillA panel of outside advisers to the U.S. health regulator on Wednesday voted against authorizing Veru Inc's drug for treating high-risk patients hospitalized with COVID-19, citing multiple concerns over efficacy and safety data being based on a small trial.
Read more »
FDA warns of animal tranquilizer in illicit drug supplyXylazine, an animal tranquilizer, is increasingly being detected in heroin and illicit fentanyl, the FDA warns. Overdoses can't be reversed with Narcan.
Read more »